Please assess the completion status of the following clinical trial:

Trial Title: Recover L-PRP in Lateral Epicondylitis (REGP-11-00)

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: OTHER
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~1. Signed an independent ethics committee (IEC)-approved informed consent form (ICF).~2. Male or female of ≥ 18 years of age~3. Confirmed diagnosis of unilateral chronic LE~4. Duration of chronic LE symptoms ≥ 3 months~5. Failed at least one previous LE treatment (e.g. wait and see, physiotherapy, analgesics, NSAIDs, anti-inflammatory steroid injection and bracing, etc.).~   Exclusion Criteria:~6. No active systemic inflammatory condition (e.g., rheumatoid arthritis)~7. No active leukemia or metastatic malignant cells~8. No current chemotherapy treatments~9. No pregnancy~10. No lactation~11. No infected tendons, skin infection or skin disease in the area of the injection site.~12. Participating in another drug or device study.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).